Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer

Clinical trial NCT03576963 · WITHDRAWN

Trial details

NCT number: NCT03576963
Sponsor: University of Southern California
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Adenocarcinoma CpG Island Methylator Phenotype Metastatic Microsatellite Stable Colorectal Carcinoma Refractory Colorectal Carcinoma Stage IV Colorectal Cancer AJCC v8 Stage IVA Colorectal Cancer AJCC v8 Stage IVB Colorectal Cancer AJCC v8 Stage IVC Colorectal Cancer AJCC v8

Start date: 2020-01-30
Primary completion: 2022-01-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.